Amgen Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
AMGN Nasdaq 2830 www.amgen.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Amgen Inc.

Can Protagonist Take On Eli Lilly's Next-Generation Obesity Treatment? - Jun 30th, 2025 2:05 pm
AMGEN ANNOUNCES POSITIVE TOPLINE PHASE 3 RESULTS FOR BEMARITUZUMAB IN FIBROBLAST GROWTH FACTOR RECEPTOR 2b (FGFR2b) POSITIVE FIRST-LINE GASTRIC CANCER - Jun 30th, 2025 7:00 am
2 Dividend Stocks to Buy on the Dip and Hold Forever - Jun 30th, 2025 3:05 am
Jim Cramer Says That Amgen’s Stock “Did Not Deserve to Get Hit This Hard” - Jun 28th, 2025 10:20 am
Amgen Looks to Take Share of Booming Obesity Space: Will It Succeed? - Jun 27th, 2025 8:10 am
Here's Why Amgen (AMGN) is a Strong Growth Stock - Jun 27th, 2025 7:45 am
Cancer Vaccine (Preventative, Therapeutic) Market Research 2025 with Analyst Recommendations-Leveraging AI and Bioinformatics for Precision Development / Pursue Fast-Track and Orphan Drug Designations - Jun 27th, 2025 7:35 am
5 Insightful Analyst Questions From Amgen’s Q1 Earnings Call - Jun 26th, 2025 2:02 am
Amgen (AMGN) Stock Moves 1.03%: What You Should Know - Jun 25th, 2025 3:50 pm
Jim Cramer on Keurig Dr Pepper: “I Don’t Want to Touch That One” - Jun 25th, 2025 2:59 pm
Here's Why Amgen (AMGN) is a Strong Value Stock - Jun 25th, 2025 7:40 am
In the wake of Amgen Inc.'s (NASDAQ:AMGN) latest US$6.5b market cap drop, institutional owners may be forced to take severe actions - Jun 25th, 2025 7:00 am
Amgen (AMGN) Falls 5.8% as Novo Nordisk Hammers Its Weight Loss Drug Trial - Jun 24th, 2025 12:07 pm
2 Small-Cap Stocks Under $10 to Buy With Big Potential - Jun 24th, 2025 5:30 am
Amgen (AMGN) Stock Slides as Market Rises: Facts to Know Before You Trade - Jun 23rd, 2025 4:00 pm
Stocks Rally on Hopes of De-Escalation of Hostilities in the Middle East - Jun 23rd, 2025 2:54 pm
Amgen Shares Fall on Weight-Loss Drug Tummy Troubles - Jun 23rd, 2025 2:15 pm
Amgen stock slips, weight-loss drug moves to phase 3 trial - Jun 23rd, 2025 1:49 pm
RESULTS FROM AMGEN'S PHASE 2 OBESITY STUDY OF MONTHLY MARITIDE PRESENTED AT THE AMERICAN DIABETES ASSOCIATION 85TH SCIENTIFIC SESSIONS - Jun 23rd, 2025 12:31 pm
Amgen gears up for phase 3 trial of monthly weight-loss drug MariTide amid mixed investor sentiment - Jun 23rd, 2025 12:30 pm